D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 60 Citations 13,128 146 World Ranking 1736 National Ranking 862

Research.com Recognitions

Awards & Achievements

2019 - Distinguished Fellows of the American Association of Immunologists (AAI)

2016 - AAI Lifetime Achievement Award, American Association of Immunologists

2016 - American Association of Immunologists Lifetime Achievement Award

Overview

What is she best known for?

The fields of study she is best known for:

  • Immune system
  • Cancer
  • Gene

The scientist’s investigation covers issues in Immunology, Antigen, Immune system, Epitope and T cell. Her Immunology study integrates concerns from other disciplines, such as Cancer research and Pancreatic cancer. Her Antigen study incorporates themes from Cancer, Cytotoxic T cell, Tumor antigen and Antibody.

Olivera J. Finn has researched Cancer in several fields, including Translational research and Computational biology. Her work carried out in the field of Epitope brings together such families of science as Molecular biology, Mucin, Monoclonal antibody and Adenocarcinoma. The various areas that Olivera J. Finn examines in her T cell study include Acquired immune system and Immunogenicity.

Her most cited work include:

  • The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research (957 citations)
  • Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. (707 citations)
  • Cancer vaccines: between the idea and the reality. (516 citations)

What are the main themes of her work throughout her whole career to date?

Immunology, Antigen, Cancer, Immune system and MUC1 are her primary areas of study. Her studies in Immunology integrate themes in fields like Cytotoxic T cell and Cancer research. Her Cytotoxic T cell research incorporates themes from CD8 and Major histocompatibility complex.

Her study explores the link between Antigen and topics such as Molecular biology that cross with problems in CTL*. Her Cancer study deals with the bigger picture of Internal medicine. Her Immune system study combines topics from a wide range of disciplines, such as Adjuvant, Disease and Vaccination.

She most often published in these fields:

  • Immunology (48.36%)
  • Antigen (35.66%)
  • Cancer (28.28%)

What were the highlights of her more recent work (between 2013-2021)?

  • Immunology (48.36%)
  • Cancer (28.28%)
  • Antigen (35.66%)

In recent papers she was focusing on the following fields of study:

Her scientific interests lie mostly in Immunology, Cancer, Antigen, Immune system and MUC1. Cancer vaccine, T cell and Vaccination are among the areas of Immunology where Olivera J. Finn concentrates her study. Her work on Immunotherapy and Cancer prevention is typically connected to Myeloid-derived Suppressor Cell as part of general Cancer study, connecting several disciplines of science.

Her Antigen research incorporates elements of Antibody, Gene, Tumor antigen and Virology. Her research in the fields of Immunosurveillance, Immunity and Autoimmunity overlaps with other disciplines such as Glycopeptide. Her study in MUC1 is interdisciplinary in nature, drawing from both Gastroenterology, Metastasis and Disease.

Between 2013 and 2021, her most popular works were:

  • The dawn of vaccines for cancer prevention (74 citations)
  • Precancer Atlas to Drive Precision Prevention Trials (69 citations)
  • Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines☆ (56 citations)

In her most recent research, the most cited papers focused on:

  • Immune system
  • Cancer
  • Gene

Olivera J. Finn focuses on Antigen, Cancer, Immune system, Immunosurveillance and Immunology. Her Antigen research is multidisciplinary, incorporating perspectives in Antibody and Tumor antigen. Her Cancer study often links to related topics such as Cancer research.

Her studies deal with areas such as Virus and Gene as well as Immune system. Her work deals with themes such as T cell and Pancreatic cancer, which intersect with Immunosurveillance. While the research belongs to areas of Immunology, Olivera J. Finn spends her time largely on the problem of Cancer prevention, intersecting her research to questions surrounding Normal tissue and Disease.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

Martin A. Cheever;Martin A. Cheever;James P. Allison;Andrea S. Ferris;Olivera J. Finn.
Clinical Cancer Research (2009)

1262 Citations

Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.

Jan Schmielau;Olivera J. Finn.
Cancer Research (2001)

1102 Citations

Cancer vaccines: between the idea and the reality.

Olivera J. Finn.
Nature Reviews Immunology (2003)

794 Citations

Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells

Donna L. Barnd;Michael S. Lan;Richard S. Metzgar;Olivera J. Finn.
Proceedings of the National Academy of Sciences of the United States of America (1989)

580 Citations

Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells.

Keith R. Jerome;Donna L. Barnd;Katharine M. Bendt;Cinda M. Boyer.
Cancer Research (1991)

535 Citations

Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients

Kotera Y;Fontenot Jd;Pecher G;Metzgar Rs.
Cancer Research (1994)

479 Citations

A phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinoma

James S. Goydos;Elaine Elder;Theresa L. Whiteside;Olivera J. Finn.
Journal of Surgical Research (1996)

373 Citations

MUC-1 Epithelial Tumor Mucin-Based Immunity and Cancer Vaccines

Olivera J. Finn;Keith R. Jerome;Robert A. Henderson;Gabriele Pecher.
Immunological Reviews (1995)

358 Citations

Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides.

C G Ioannides;B Fisk;K R Jerome;T Irimura.
Journal of Immunology (1993)

284 Citations

MCF7 Side Population Cells with Characteristics of Cancer Stem/Progenitor Cells Express the Tumor Antigen MUC1

Katja Engelmann;Hongmei Shen;Olivera J. Finn.
Cancer Research (2008)

280 Citations

Best Scientists Citing Olivera J. Finn

Surinder K. Batra

Surinder K. Batra

University of Nebraska Medical Center

Publications: 46

Mary L. Disis

Mary L. Disis

Fred Hutchinson Cancer Research Center

Publications: 43

Joyce Taylor-Papadimitriou

Joyce Taylor-Papadimitriou

King's College London

Publications: 43

Sandra J. Gendler

Sandra J. Gendler

Mayo Clinic

Publications: 41

Haruo Sugiyama

Haruo Sugiyama

Osaka University

Publications: 38

Joy M. Burchell

Joy M. Burchell

King's College London

Publications: 34

Vasso Apostolopoulos

Vasso Apostolopoulos

Victoria University

Publications: 32

Michael A. Hollingsworth

Michael A. Hollingsworth

University of Nebraska Medical Center

Publications: 32

Dmitry I. Gabrilovich

Dmitry I. Gabrilovich

AstraZeneca (United Kingdom)

Publications: 31

Jacques Banchereau

Jacques Banchereau

Immunai

Publications: 31

Donald Kufe

Donald Kufe

Harvard University

Publications: 31

Vincenzo Bronte

Vincenzo Bronte

University of Verona

Publications: 29

Theresa L. Whiteside

Theresa L. Whiteside

University of Pittsburgh

Publications: 29

Jianlin Gong

Jianlin Gong

Boston University

Publications: 28

Henrik Clausen

Henrik Clausen

University of Copenhagen

Publications: 27

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us
Something went wrong. Please try again later.